Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

3.

Toll-like receptor 2 and 4 (TLR2 and TLR4) agonists differentially regulate secretory interleukin-1 receptor antagonist gene expression in macrophages.

Carl VS, Brown-Steinke K, Nicklin MJ, Smith MF Jr.

J Biol Chem. 2002 May 17;277(20):17448-56. Epub 2002 Mar 4.

4.

Endotoxin-induced maturation of MyD88-deficient dendritic cells.

Kaisho T, Takeuchi O, Kawai T, Hoshino K, Akira S.

J Immunol. 2001 May 1;166(9):5688-94.

6.

Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation.

Hoshino K, Kaisho T, Iwabe T, Takeuchi O, Akira S.

Int Immunol. 2002 Oct;14(10):1225-31.

PMID:
12356687
7.

Activation of human meningeal cells is modulated by lipopolysaccharide (LPS) and non-LPS components of Neisseria meningitidis and is independent of Toll-like receptor (TLR)4 and TLR2 signalling.

Humphries HE, Triantafilou M, Makepeace BL, Heckels JE, Triantafilou K, Christodoulides M.

Cell Microbiol. 2005 Mar;7(3):415-30.

PMID:
15679844
8.

Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut.

Melmed G, Thomas LS, Lee N, Tesfay SY, Lukasek K, Michelsen KS, Zhou Y, Hu B, Arditi M, Abreu MT.

J Immunol. 2003 Feb 1;170(3):1406-15.

10.
11.

Heat-killed Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways: TNF, unlike IL-12p40 secretion, is Toll-like receptor 2 dependent.

Huang LY, Aliberti J, Leifer CA, Segal DM, Sher A, Golenbock DT, Golding B.

J Immunol. 2003 Aug 1;171(3):1441-6.

12.
13.

Toll and Toll-like proteins: an ancient family of receptors signaling infection.

Imler JL, Hoffmann JA.

Rev Immunogenet. 2000;2(3):294-304. Review.

PMID:
11256741
14.

A novel class of endotoxin receptor agonists with simplified structure, toll-like receptor 4-dependent immunostimulatory action, and adjuvant activity.

Hawkins LD, Ishizaka ST, McGuinness P, Zhang H, Gavin W, DeCosta B, Meng Z, Yang H, Mullarkey M, Young DW, Yang H, Rossignol DP, Nault A, Rose J, Przetak M, Chow JC, Gusovsky F.

J Pharmacol Exp Ther. 2002 Feb;300(2):655-61.

15.

Stimulation of toll-like receptor 2 by Coxiella burnetii is required for macrophage production of pro-inflammatory cytokines and resistance to infection.

Zamboni DS, Campos MA, Torrecilhas AC, Kiss K, Samuel JE, Golenbock DT, Lauw FN, Roy CR, Almeida IC, Gazzinelli RT.

J Biol Chem. 2004 Dec 24;279(52):54405-15. Epub 2004 Oct 13.

16.

Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts-CD14 and Toll-like receptors.

Wang PL, Ohura K.

Crit Rev Oral Biol Med. 2002;13(2):132-42. Review.

PMID:
12097356
17.

Lipopolysaccharides from Helicobacter pylori can act as antagonists for Toll-like receptor 4.

Lepper PM, Triantafilou M, Schumann C, Schneider EM, Triantafilou K.

Cell Microbiol. 2005 Apr;7(4):519-28.

PMID:
15760452
18.

Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells.

Varadaradjalou S, Féger F, Thieblemont N, Hamouda NB, Pleau JM, Dy M, Arock M.

Eur J Immunol. 2003 Apr;33(4):899-906.

19.

Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways.

Henneke P, Takeuchi O, Malley R, Lien E, Ingalls RR, Freeman MW, Mayadas T, Nizet V, Akira S, Kasper DL, Golenbock DT.

J Immunol. 2002 Oct 1;169(7):3970-7.

20.

Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.

Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA.

Hepatology. 2003 May;37(5):1043-55.

PMID:
12717385

Supplemental Content

Support Center